RE:RE:RE:RE:RE:Not exactly price dilution?The aim should be to finance at progressively higher prices based on good results. This is going the other way despite some interesting assays. This looks like the money that wasn't raised in the last financing that fell short, at higher prices. Does this new raise get TUD to the end of the year?